Viking Therapeutics

YTD

ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.

CEO

Brian Lian

CEOBrian Lian

Employees

Employees36

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees36

VKTX Key Statistics

Market cap

3.49B

Market cap3.49B

Price-Earnings ratio

-27.01

Price-Earnings ratio-27.01

Dividend yield

—

Dividend yield—

Average volume

4.15M

Average volume4.15M

High today

$31.28

High today$31.28

Low today

$30.17

Low today$30.17

Open price

$30.96

Open price$30.96

Volume

2.83M

Volume2.83M

52 Week high

$81.73

52 Week high$81.73

52 Week low

$18.92

52 Week low$18.92

VKTX News

Simply Wall St 6d

This Insider Has Just Sold Shares In Viking Therapeutics

Some Viking Therapeutics, Inc. ( ) shareholders may be a little concerned to see that the President, Brian Lian, recently sold a substantial US$748k worth of st...

Analyst ratings

89%

of 19 ratings

Buy

89.5%

Hold

10.5%

Sell

People also own

Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.

Catalyst Pharmaceuticals

Corbus Pharmaceuticals